1887

Abstract

This study investigated the species prevalence and antibacterial resistance among enterococci isolated in Kuwait hospitals. They consisted of 415 isolates of (85.3 %), (7.7 %), (4.0 %), (1.2 %), (1.0 %), (0.5 %) and (0.2 %) isolated from urine (36.6 %), blood (10.4 %), wound swabs (11.0 %), stool samples (12.0 %), high vaginal swabs (9.0 %), endocervical swabs (3.0 %) and miscellaneous sources (18.0 %). All of them were susceptible to linezolid. Fifty-two (12.5 %) isolates were ampicillin resistant but none of them produced β-lactamase. They were resistant to erythromycin (63.3 %), tetracycline (60.5 %), ciprofloxacin (40.0 %), chloramphenicol (28.0 %), vancomycin (2.6 %), and teicoplanin (2.6 %). Fourteen, 19 and 20 % of them expressed high-level resistance to gentamicin, kanamycin and streptomycin, respectively. All of the vancomycin-resistant strains carried the phenotype and genotype. There was no evidence of clonal spread of the vancomycin-resistant isolates.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.04949-0
2003-02-01
2019-10-14
Loading full text...

Full text loading...

/deliver/fulltext/jmm/52/2/163.html?itemId=/content/journal/jmm/10.1099/jmm.0.04949-0&mimeType=html&fmt=ahah

References

  1. Arthur, M. & Courvalin, P. ( 1993;). Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother 37, 1563–1571.[CrossRef]
    [Google Scholar]
  2. Cetinkaya, Y., Falk, P. & Mayhall, C. G. ( 2000;). Vancomycin-resistant enterococci. Clin Microbiol Rev 13, 686–707.[CrossRef]
    [Google Scholar]
  3. Donskey, C. J., Schreiber, J. R., Jacobs, M. R., Sheker, R., Salata, R. A., Gordo, S., Whalen, C. C., Smith, F. & Rice, L. B. ( 1999;). A polyclonal outbreak of predominantly vanB vancomycin-resistant enterococci in North East Ohio. Northeast Ohio vancomycin-resistant enterococcus surveillance program. Clin Infect Dis 29, 573–579.[CrossRef]
    [Google Scholar]
  4. Dutka-Malen, S., Evers, S. & Courvalin, P. ( 1995;). Detection of glycopeptide resistance and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 33, 24–27.
    [Google Scholar]
  5. Huycke, M. M., Sahm, D. F. & Gilmore, M. S. ( 1998;). Multiple-drug resistant enterococci: The nature of the problem and an agenda for the future. Emerg Infect Dis 4, 239–249.[CrossRef]
    [Google Scholar]
  6. Ieven, M., Vercauteren, E., Deschemaeker, P., Van Laer, F. & Goossens, H. ( 1999;). Comparison of direct plating and broth enrichment culture for the detection of intestinal colonisation by glycopeptide-resistant enterococci among hospitalized patients. J Clin Microbiol 37, 1436–1440.
    [Google Scholar]
  7. Jones, R. N., Marshall, S. A., Pfaller, M. A., Wilke, W. W., Hollis, R. J., Erwin, M. E., Edmond, M. B. & Wenzel, R. P. ( 1997;). Nosocomial enterococcal bloodstream infections in the SCOPE program: antimicrobial resistance, species occurrence, molecular testing results and laboratory testing accuracy. SCOPE Hospital Study Group. Diagn Microbiol Infect Dis 29, 95–102.[CrossRef]
    [Google Scholar]
  8. Jordens, J. Z., Bates, J. & Griffiths, D. J. (1994). Fecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother 34, 515–528.
  9. Leber, A. l., Hindler, J. F., Kato, E. O., Bruckner, D. A. & Peques, D. A. ( 2001;). Laboratory based surveillance for vancomycin-resistant enterococci: utility of screening stool specimens submitted for Clostridium toxin assay. Infect Control Hosp Epidemiol 22, 160–164.[CrossRef]
    [Google Scholar]
  10. Leclercq, R., Derlot, E., Weber, M., Duval, J. & Courvalin, P. ( 1989;). Transferable vancomycin and teicoplanin resistance in Enterococcus faecium. Antimicrob Agents Chemother 33, 10–15.[CrossRef]
    [Google Scholar]
  11. Linden, P. K., Pasculle, A. W., Manez, R., Kramer, D. J., Fung, J. J., Pinna, A. D. & Kusne, S. ( 1996;). Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin susceptible E. faecium. Clin Infect Dis 22, 663–670.[CrossRef]
    [Google Scholar]
  12. Miele, A., Bandera, M. & Goldstein, B. P. ( 1995;). Use of primers selective for vancomycin resistance genes to determine van genotypes in enterococci and to study gene organisation in vanA isolates. Antimicrob Agents Chemother 39, 1772–1778.[CrossRef]
    [Google Scholar]
  13. Morrison, D., Woodford, N., Barrett, S. P., Sisson, P. & Cookson, B. D. ( 1999;). DNA banding pattern polymorphism in vancomycin-resistant Enterococcus faecium and criteria for defining strains. J Clin Microbiol 37, 1084–1091.
    [Google Scholar]
  14. National Committee for Clinical Laboratory Standards (2000). Performance standard for disk susceptibility tests. Approved Standard 7th edn. Wayne, PA: National Committee for Clinical Laboratory Standards.
  15. Nelson, R. R. S., McGregor, K. F., Brown, A. R., Amyes, S. G. B. & Young, H.-K. ( 2000;). Isolation and characterization of glycopeptide-resistant enterococci from hospitalized patients over a 30-month period. J Clin Microbiol 38, 2112–2116.
    [Google Scholar]
  16. Perlada, D. E., George, S. A. & Cushion, M. T. ( 1997;). Molecular epidemiology and antibiotic susceptibility of enterococci in Cincinnati, Ohio: a prospective citywide survey. J Clin Microbiol 35, 2342–2347.
    [Google Scholar]
  17. Quale, J., Laudman, D., Atwood, E. & 9 other authors ( 1996;). Experience with a hospital-wide outbreak of vancomycin-resistant enterococci. Am J Infect Control 24, 372–379.[CrossRef]
    [Google Scholar]
  18. Reinert, R. R., Conrad, G., Schaeger, J. J., Werner, G., Witte, W., Lutticken, R. & Klare, I. ( 1999;). Survey of antibiotic resistance among enterococci in North Rhine-Wesphalia, Germany. J Clin Microbiol 37, 1638–1641.
    [Google Scholar]
  19. Schouten, M. A., Hoogkamp-Korstanje, J. A., Meis, J. F. & Voss, A. (2000). Prevalence of vancomycin-resistant enterococci in Europe. Eur J Clin Microbiol Infect Dis 19, 816–822.
  20. Shlaes, D. M., Al-Obeid, S., Shlaes, J. H., Boisivon, A. & Williamson, R. ( 1989;). Inducible, transferable resistance to vancomycin in Enterococcus faecium, D399. J Antimicrob Chemother 23, 503–508.[CrossRef]
    [Google Scholar]
  21. Toutouza, M., Skandami, V., Poujiouka-Bei, M., Fakiri, H., Karabassi, V., Komniou, ( 2001;). Resistance phenotypes in enterococci isolated from clinical specimens during a 3-year period. Clin Microbiol Infect 7 (Suppl. 1), 81.
    [Google Scholar]
  22. Udo, E. E. & Dashti, A. A. ( 2000;). Detection of genes encoding aminoglycoside modifying enzymes in Staphylococci by polymerase chain reaction and dot blot hybridization. Int J Antimicrob Agents 13, 273–279.[CrossRef]
    [Google Scholar]
  23. Werner, G., Klare, I. & Witte, W. ( 1999;). Large conjugative vanA plasmids in vancomycin-resistant Enterococcus faecium. J Clin Microbiol 37, 2383–2384.
    [Google Scholar]
  24. Woodford, N., Johnson, A. P. & George, R. C. (1991). Detection of glycopeptide resistance in clinical isolates of Gram-positive bacteria. J Antimicrob Chemother 28, 483–486.
  25. Woodford, N., Morrison, D., Johnson, A. P. & George, R. C. ( 1993;). Antimicrobial resistance amongst enterococci isolated in the United Kingdom: a reference laboratory perspective. J Antimicrob Chemother 32, 344–346.[CrossRef]
    [Google Scholar]
  26. Zouain, M. G. &, Araj, G. F. ( 2001;). Antimicrobial resistance of Enterococci in Lebanon. Int J Antimicrob Agents 17, 209–213.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.04949-0
Loading
/content/journal/jmm/10.1099/jmm.0.04949-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error